Cited 0 times in
Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김범석 | - |
dc.contributor.author | 윤호근 | - |
dc.contributor.author | 임범진 | - |
dc.date.accessioned | 2025-08-18T05:50:18Z | - |
dc.date.available | 2025-08-18T05:50:18Z | - |
dc.date.issued | 2025-07 | - |
dc.identifier.issn | 1757-4676 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/207201 | - |
dc.description.abstract | Chronic kidney disease (CKD) has a high prevalence worldwide and is typically accompanied by severe fibrosis. However, the exact pathogenesis of renal fibrosis and effective treatments have yet to be identified. In this study, we found that expression of the histone-acetyltransferase p300 was increased in focal segmental glomerulosclerosis patients and several distinct mouse models of renal fibrosis. Moreover, we showed that the AKT-mediated phosphorylation of Ser-1834 of p300 increased the stability of p300 upon renal fibrosis induction, and conversely, PPM1K specifically dephosphorylated p300 at Ser-1834, resulting in a significant reduction in p300 stability and renal fibrosis. Interestingly, increased p300 in proximal tubular cells (PTCs) promoted renal fibrosis development by mediating the endothelial to mesenchymal transition (EndMT) via upregulation of the mesenchymal-transition-related secreted proteins POSTN, FSTL1, and FSCN1. Both EndMT and renal fibrosis were significantly diminished by either PTC-specific deletion of p300 gene or selective inhibitors of p300. Collectively, our results demonstrate the role of p300 in the development of renal fibrosis, and suggest that p300 is a promising target for treatment of advanced CKD. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Wiley-Blackwell | - |
dc.relation.isPartOf | EMBO MOLECULAR MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Animals | - |
dc.subject.MESH | Disease Models, Animal | - |
dc.subject.MESH | E1A-Associated p300 Protein* / genetics | - |
dc.subject.MESH | E1A-Associated p300 Protein* / metabolism | - |
dc.subject.MESH | Endothelial-Mesenchymal Transition | - |
dc.subject.MESH | Epithelial-Mesenchymal Transition* | - |
dc.subject.MESH | Fibrosis* / pathology | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Kidney Tubules, Proximal* / metabolism | - |
dc.subject.MESH | Kidney Tubules, Proximal* / pathology | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Mice | - |
dc.subject.MESH | Renal Insufficiency, Chronic / pathology | - |
dc.title | Loss of p300 in proximal tubular cells reduces renal fibrosis and endothelial-mesenchymal transition | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Hyunsik Kim | - |
dc.contributor.googleauthor | Soo-Yeon Park | - |
dc.contributor.googleauthor | Soo Yeon Lee | - |
dc.contributor.googleauthor | Jae-Hwan Kwon | - |
dc.contributor.googleauthor | Seunghee Byun | - |
dc.contributor.googleauthor | Byounghwi Ko | - |
dc.contributor.googleauthor | Jung-Yoon Yoo | - |
dc.contributor.googleauthor | Beom Seok Kim | - |
dc.contributor.googleauthor | Beom Jin Lim | - |
dc.contributor.googleauthor | Ho-Geun Yoon | - |
dc.identifier.doi | 10.1038/s44321-025-00243-1 | - |
dc.contributor.localId | A00488 | - |
dc.contributor.localId | A02625 | - |
dc.contributor.localId | A03363 | - |
dc.relation.journalcode | J00764 | - |
dc.identifier.eissn | 1757-4684 | - |
dc.identifier.pmid | 40588562 | - |
dc.subject.keyword | Chronic Kidney Disease | - |
dc.subject.keyword | Endothelial-mesenchymal Transition | - |
dc.subject.keyword | Renal Fibrosis, Proximal Tubular Cells | - |
dc.subject.keyword | p300 | - |
dc.contributor.alternativeName | Kim, Beom Seok | - |
dc.contributor.affiliatedAuthor | 김범석 | - |
dc.contributor.affiliatedAuthor | 윤호근 | - |
dc.contributor.affiliatedAuthor | 임범진 | - |
dc.citation.volume | 17 | - |
dc.citation.number | 7 | - |
dc.citation.startPage | 1575 | - |
dc.citation.endPage | 1598 | - |
dc.identifier.bibliographicCitation | EMBO MOLECULAR MEDICINE, Vol.17(7) : 1575-1598, 2025-07 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.